Albuminuria, a Therapeutic Target for Cardiovascular Protection in Type 2 Diabetic Patients With Nephropathy

2004751 citationsJournal Article

Authors

Dick de Zeeuw · Aarhus University

Giuseppe Remuzzi · Mario Negri Institute for Pharmacological Research

Hans‐Henrik Parving · University Medical Center Groningen

William F. Keane · Aarhus University

Zhongxin Zhang · University Medical Center Groningen

Shahnaz Shahinfar · Steno Diabetes Center

Steve Snapinn

Abstract

Albuminuria is an important factor predicting cardiovascular risk in patients with type 2 diabetic nephropathy. Reducing albuminuria in the first 6 months appears to afford cardiovascular protection in these patients.

Topics & Keywords

Blood Pressure and Hypertension Studies Chronic Kidney Disease and Diabetes Renin-Angiotensin System Studies

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Circulation

Volume 110, Issue 8, pp. 921-927

DOI: 10.1161/01.cir.0000139860.33974.28

Field-Weighted Citation Impact: 33.26